Associated Papers
Deciphering the pathogenicity of three NKX2-1 variants in ultra-severe forms of childhood interstitial lung disease.
Soreze YD et al.
Plos One, 2025
A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects Only in the Presence of PAX8.
Shinohara H et al.
Thyroid : Official Journal of the American Thyroid Association, 2018
NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome".
Guillot L et al.
Human Mutation, 2010
Select a paper to view details